NCT03598465View on ClinicalTrials.gov

Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure

CompletedOBSERVATIONAL
Enrollment

591

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

September 1, 2024

Study Completion Date

October 1, 2024

Conditions
Post-hepatectomy Liver Failure
Trial Locations (3)

510515

Nanfang Hospital, Southern Medical University, Guangzhou

518035

The second people's hospital of Shenzhen, Shenzhen

528300

The first people's hospital of Foshan, Foshan

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER

NCT03598465 - Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure | Biotech Hunter | Biotech Hunter